tiprankstipranks
Korsana Biosciences (KRSA)
NASDAQ:KRSA
US Market
Want to see KRSA full AI Analyst Report?

Korsana Biosciences (KRSA) Financial Statements

273 Followers

Korsana Biosciences Financial Overview

Korsana Biosciences's market cap is currently $16.42M. The company's EPS TTM is $; its P/E ratio is -2.65; Korsana Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 2.07M$ 2.00M$ 0.00$ 297.00K$ 3.32M
Gross Profit$ 2.07M$ 2.00M$ -1.31M$ -5.28M$ 3.32M
Operating Income$ -4.97M$ -3.63M$ -12.95M$ -18.54M$ -55.20M
EBITDA$ -3.53M$ -3.06M$ -9.58M$ -18.18M$ -53.84M
Net Income$ -3.53M$ -3.06M$ -5.26M$ -44.08M$ -51.65M
Balance Sheet
Cash & Short-Term Investments$ 3.24M$ 3.23M$ 7.57M$ 13.38M$ 53.96M
Total Assets$ 9.98M$ 9.57M$ 13.37M$ 18.08M$ 59.33M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.24M$ -3.23M$ -7.57M$ -13.38M$ -53.96M
Total Liabilities$ 900.00K$ 725.00K$ 2.09M$ 7.63M$ 11.09M
Stockholders' Equity$ 9.09M$ 8.85M$ 11.29M$ 10.45M$ 48.25M
Cash Flow
Free Cash Flow$ -3.31M$ -4.33M$ -21.25M$ -40.61M$ -36.52M
Operating Cash Flow$ -3.31M$ -4.33M$ -21.25M$ -40.61M$ -36.52M
Investing Cash Flow$ 0.00$ 0.00$ 10.40M$ 0.00$ 1.46M
Financing Cash Flow$ 3.32M$ 0.00$ 5.02M$ 29.00K$ 30.79M
Currency in USD

Korsana Biosciences Earnings and Revenue History

Korsana Biosciences Debt to Assets

Korsana Biosciences Cash Flow

Korsana Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.